Lichen International Ltd
LICN
$0.53
▼
-0.12
(-18.38%)
at close
7
Visible periods
4
Metrics
Peer-ranked
Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome
Analytical Summary
Lichen International Ltd faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
—
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Nov 5, 2026.
trending_up
Bullish Indicators
- No bullish signals detected.
warning
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Returns
23
Financial Health
11
Cash Quality ↓
55
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is the balance sheet risky?
2 metrics
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q4 FY2021 Dec 31, 2021 20-F ↗ | Q4 FY2020 Dec 31, 2020 20-F ↗ | Q4 FY2019 Dec 31, 2019 20-F ↗ |
|---|---|---|---|---|---|---|---|
| Debt to Equity (x) | — | — |
0.03x
Excellent
↑
Excellent
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-96%)
|
0.03x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-96%)
|
0.01x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-99%)
|
— | — |
| Net Debt (USD) | $-26.91M | $-26.71M | $-24.27M | $-21.54M | $-16.50M | — | — |
How resilient is the balance sheet?
2 metrics
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q4 FY2021 Dec 31, 2021 20-F ↗ | Q4 FY2020 Dec 31, 2020 20-F ↗ | Q4 FY2019 Dec 31, 2019 20-F ↗ |
|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $31.49M | $29.74M | $36.04M | $22.04M | $17.78M | — | — |
| Total Equity (USD) | $70.55M | $73.18M | $61.42M | $41.11M | $36.83M | $27.64M | $23.73M |
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare LICN against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare LICN against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for LICN
Bullish
0
No bullish signals detected
Bearish
1
Return on Common Equity (%)
-31.1%
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How LICN compares to all companies
Return on Common Equity (%)
-31.1%
Bottom 25%
Peers: Top 60%
Peer Comparison
LICN vs similar peers
Return on Common Equity (%)
LICN
-31.1%
#12 of 19
ACCL
46.7%
EUBG
18.2%
ZTG
14.5%
Peer median: -6.71
Profit Margin (%)
LICN
—
#None of 2
CTM
-4.5%
AERT
-30.8%
Peer median: -17.65
Debt to Equity
LICN
—
#None of 5
CISO
0.00x
INTJ
0.01x
SUPX
0.01x
Peer median: 0.01
Operating Margin (%)
LICN
—
#None of 2
CTM
-5.3%
AERT
-41.0%
Peer median: -23.15
Compare LICN with peers
Stack LICN against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 4 days ago 7 years · 7 quarters